Astraveus Announces World First End-to-End Production of CAR-T Cells Using Microfluidic Technology

Cell therapy

Astraveus SAS, the Benchtop Cell Factory company, today announces the first ever successful end-to-end production of CAR-T cells within a microfluidic benchtop system. Using its fully automated Lakhesys Benchtop Cell Factory™, Astraveus has been able to demonstrate the potential of its unique microfluidic cell therapy processing approach, which has the ability to decrease manufacturing costs and increase throughput by an order of magnitude.

More infos

Back to news